Actor
VeoSource SA
First technology application is designed to protect the brain for a finite time following a heart procedure or TAVI.
The Aura is to be deployed percutaneously via the brachial artery prior the heart intervention to deflect any potential emboli away from the brain
Specialties
Primary Therapeutic Areas
1.5 Medical Technology
1.51 Cardiovascular device
Business model
1. Entreprise
1.2 Scale-Up
Organization Type
Private Company
Visit website
Domains
Cardiovascular & Hematology
Main sector
Medtech
Contact
EPFL Innovation Park, Bât. C
1015 Lausanne / VD